Last reviewed · How we verify

Alfentanil Hydrochloride Injection

The First Affiliated Hospital of Xinxiang Medical College · FDA-approved active Small molecule

Alfentanil is a potent synthetic opioid agonist that binds to mu (μ) opioid receptors in the central nervous system to produce rapid analgesia and sedation.

Alfentanil is a potent synthetic opioid agonist that binds to mu (μ) opioid receptors in the central nervous system to produce rapid analgesia and sedation. Used for Analgesia and sedation during anesthesia, Acute pain management in perioperative settings, Sedation in intensive care units.

At a glance

Generic nameAlfentanil Hydrochloride Injection
SponsorThe First Affiliated Hospital of Xinxiang Medical College
Drug classOpioid agonist
TargetMu (μ) opioid receptor
ModalitySmall molecule
Therapeutic areaAnesthesia and Pain Management
PhaseFDA-approved

Mechanism of action

Alfentanil acts as a selective agonist at mu opioid receptors, which are distributed throughout the brain and spinal cord. This binding modulates pain perception and produces sedative effects. Due to its rapid onset and short duration of action, alfentanil is particularly useful for intravenous administration in acute care settings such as anesthesia and intensive care.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: